CN108392495A - 止痒消炎软膏 - Google Patents

止痒消炎软膏 Download PDF

Info

Publication number
CN108392495A
CN108392495A CN201810488103.5A CN201810488103A CN108392495A CN 108392495 A CN108392495 A CN 108392495A CN 201810488103 A CN201810488103 A CN 201810488103A CN 108392495 A CN108392495 A CN 108392495A
Authority
CN
China
Prior art keywords
parts
antipruritic
inflammatory
weight
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810488103.5A
Other languages
English (en)
Inventor
高伟玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810488103.5A priority Critical patent/CN108392495A/zh
Publication of CN108392495A publication Critical patent/CN108392495A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明公开了一种止痒消炎软膏，由以下重量份的组份组成的：凡士林60‑200份、十八醇40‑90份、冰片20‑80份、软皂30‑120份、麝香10‑60份、甘油40‑130份、水800‑3200份、羊毛脂40‑90份、硬脂酸80‑520份、薄荷脑80‑320份、氯霉素80‑320份、三乙醇胺10‑60份。还包括以下重量份的组份：氯倍他素0.2‑0.8份，尼泊金乙酯4‑12份。本发明相水相比例适中，对皮肤有很好的保护透皮吸收的作用，冰片、麝香、薄荷脑对皮肤镇静止痒很好，氯倍他素和氯霉素外用协同抗炎抗过敏作用很好，综上所述，本配方的药物有互相协同促进作用，药物能透皮很好的吸收利用。

Description

止痒消炎软膏
技术领域
本发明涉及中药膏技术领域，尤其涉及一种止痒消炎软膏。
背景技术
湿疹、皮炎、神经性皮炎、银屑病、白癜风等是常见的皮肤病，其发病起来大多瘙痒难耐，患者大多不受控制的挠痒，从而使得皮肤被挠破烂，加重了病情。
在现有技术中也有外用的软膏，然而其大多起效慢，不能很好的穿透皮肤，并且止痒较慢，增加了病人的痛苦，对许多顽固性皮肤病不能起效。
因此，有必要提供一种全新的止痒消炎软膏，以解决上述现有技术中存在的缺陷。
发明内容
为解决上述技术问题，本发明提供了一种止痒消炎软膏，可以有效快速的止痒消炎，在短时间内能起效，治愈病痛。
本发明提供的止痒消炎软膏，采用如下技术方案：
一种止痒消炎软膏，由以下重量份的组份组成的：凡士林60-200份、十八醇40-90份、冰片20-80份、软皂30-120份、麝香10-60份、甘油40-130份、水800-3200份、羊毛脂40-90份、硬脂酸80-520份、薄荷脑80-320份、氯霉素80-320份、三乙醇胺10-60份。
优选的，由以下重量份的组份组成的：凡士林80-150份，十八醇50-80份，冰片30-50份，软皂50-100份，麝香20-50份，甘油50-120份，水1000-3000份，羊毛脂50-80份，硬脂酸100-500份，薄荷脑100-300份，氯霉素100-300份，三乙醇胺20-50份。
进一步的，一种止痒消炎软膏，还包括以下重量份的组份：氯倍他素0.2-0.8份，尼泊金乙酯4-12份。
优选的，还包括以下重量份的组份：氯倍他素0.3-0.5份，尼泊金乙酯5-10份。
与相关技术相比，本发明具有如下技术效果：
本发明相水相比例适中，对皮肤有很好的保护透皮吸收的作用，冰片、麝香、薄荷脑对皮肤镇静止痒很好，氯倍他素和氯霉素外用协同抗炎抗过敏作用很好，综上所述，本配方的药物有互相协同促进作用，药物能透皮很好的吸收利用，对许多顽固性皮肤病如湿疹、皮炎、神经性皮炎、银屑病、白癜风等有独到的效果。临床应用诊治患者数十万人次有效率达99％以上。
具体实施方式
下面将结合实施方式对本发明作进一步说明。
实施例1
本发明的一种止痒消炎软膏，由以下重量份的组份组成的：凡士林80份、十八醇50份、冰片30份、软皂50份、麝香20份、甘油50份、水1000份、羊毛脂50份、硬脂酸100份、薄荷脑100份、氯霉素100份、三乙醇胺20份。
还包括以下重量份的组份：氯倍他素0.3份，尼泊金乙酯5份。
实施例2
在本实施例中，一种止痒消炎软膏，由以下重量份的组份组成的：凡士林150份、十八醇80份、冰片50份、软皂100份、麝香50份、甘油120份、水3000份、羊毛脂80份、硬脂酸500份、薄荷脑300份、氯霉素300份、三乙醇胺50份。
还包括以下重量份的组份：氯倍他素0.5份，尼泊金乙酯10份。
实施例3
在本实施例中，一种止痒消炎软膏，由以下重量份的组份组成的：凡士林120份、十八醇60份、冰片40份、软皂75份、麝香35份、甘油85份、水1500份、羊毛脂65份、硬脂酸300份、薄荷脑200份、氯霉素200份、三乙醇胺35份。
还包括以下重量份的组份：氯倍他素0.4份，尼泊金乙酯8份。
临床实例：
胡某某，女，62岁，以“小腿皮炎数十年”之主诉来院。入院查：患者双小腿可见密集的半球状韧性丘疹，约米粒至黄豆大小，伴明显抓痕，触之似皮革状。遂给予止痒消炎软膏两盒外用，两周后复诊，患者自觉明显好多了，双小腿也光滑了。
杨某某，男，38岁，全身可见散在的境界清楚大小不一的红色斑块，表面覆盖较厚层白色鳞屑，用棉签刮之，鳞屑易于脱落可见薄膜现象和点状出血现象。遂给予止痒消炎软膏外擦，两周后患者皮损消退，皮肤大致恢复正常。
张某某，女，16岁，以“全身反复瘙痒，抓破流水两月”之主诉入院。入院查皮肤专科情况:全身可见大片境界模糊的糜烂渗出面，尤以躯干和下肢为重。入院后给予止痒消炎软膏湿敷皮损处，十五分钟后，渗出明显减少，遂用止痒消炎软膏外擦，口服氯雷他定片，如此反复治疗五天后，患者皮肤基本恢复正常。
以上所述仅为本发明的实施例，并非因此限制本发明的专利范围，凡是利用本发明说明书所作的等效结构或等效流程变换，或直接或间接运用在其它相关的技术领域，均同理包括在本发明的专利保护范围内。

Claims (4)

1.止痒消炎软膏，其特征在于是由以下重量份的组份组成的：凡士林60-200份、十八醇40-90份、冰片20-80份、软皂30-120份、麝香10-60份、甘油40-130份、水800-3200份、羊毛脂40-90份、硬脂酸80-520份、薄荷脑80-320份、氯霉素80-320份、三乙醇胺10-60份。
2.如权利要求1所述的止痒消炎软膏，其特征在于是由以下重量份的组份组成的：凡士林80-150份，十八醇50-80份，冰片30-50份，软皂50-100份，麝香20-50份，甘油50-120份，水1000-3000份，羊毛脂50-80份，硬脂酸100-500份，薄荷脑100-300份，氯霉素100-300份，三乙醇胺20-50份。
3.如权利要求1或2所述的止痒消炎软膏，其特征在于所述软膏还包括以下重量份的组份：氯倍他素0.2-0.8份，尼泊金乙酯4-12份。
4.如权利要求3所述的止痒消炎软膏，其特征在于所述软膏包括以下重量份的组份：氯倍他素0.3-0.5份，尼泊金乙酯5-10份。
CN201810488103.5A 2018-05-21 2018-05-21 止痒消炎软膏 Pending CN108392495A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810488103.5A CN108392495A (zh) 2018-05-21 2018-05-21 止痒消炎软膏

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810488103.5A CN108392495A (zh) 2018-05-21 2018-05-21 止痒消炎软膏

Publications (1)

Publication Number Publication Date
CN108392495A true CN108392495A (zh) 2018-08-14

Family

ID=63102513

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810488103.5A Pending CN108392495A (zh) 2018-05-21 2018-05-21 止痒消炎软膏

Country Status (1)

Country Link
CN (1) CN108392495A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112791049A (zh) * 2021-04-02 2021-05-14 中国人民解放军空军军医大学 一种治疗白癜风的辛伐他汀软膏制备方法及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152546A (zh) * 2007-10-09 2008-04-02 西藏芝芝药业有限公司 具有消炎、止痒和消毒杀菌功效的外用制剂及制法
CN102366437A (zh) * 2011-07-15 2012-03-07 吉林敖东集团大连药业股份有限公司 一种复方地塞米松软膏及其制备方法
CN103860567A (zh) * 2014-04-02 2014-06-18 符代兵 一种治疗皮肤病的外用药物及其制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152546A (zh) * 2007-10-09 2008-04-02 西藏芝芝药业有限公司 具有消炎、止痒和消毒杀菌功效的外用制剂及制法
CN102366437A (zh) * 2011-07-15 2012-03-07 吉林敖东集团大连药业股份有限公司 一种复方地塞米松软膏及其制备方法
CN103860567A (zh) * 2014-04-02 2014-06-18 符代兵 一种治疗皮肤病的外用药物及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112791049A (zh) * 2021-04-02 2021-05-14 中国人民解放军空军军医大学 一种治疗白癜风的辛伐他汀软膏制备方法及其应用

Similar Documents

Publication Publication Date Title
CN105395577B (zh) 一种降尿酸组合物及其制剂
US10596148B2 (en) Topical compositions for treatment of psoriasis
CN102481290A (zh) 用于治疗红斑痤疮或红脸相关皮肤病的含黄连素或其类似物的组合物
CN107260636A (zh) 一种护肤液及其制备方法
CN108836979A (zh) 一种医用透明质酸钠修复贴及该修复贴与该修复贴精华液的制备方法
CN104013878B (zh) 一种治疗脚气的足浴药醋及其制备方法
CN108653479A (zh) 一种治疗顽固性皮肤病的中药组合物及其制备方法与应用
CN103127140A (zh) 一种治疗银屑病的复方外用药物
CN108392495A (zh) 止痒消炎软膏
CN104784223A (zh) 一种具有止痒功能的组合物及其制备方法
CN101066285B (zh) 虫草制剂作为制备治疗皮肤疾病药物的应用
CN101829178A (zh) 一种治疗尿布疹的药物组合物及其制备方法
CN101229258B (zh) 抗过敏消炎膏
CN100441206C (zh) 一种治疗皮肤烫、创伤和疮疡的复方药及其制备方法
CN1706381A (zh) 一种治疗冻伤和冻疮的软膏
Lavanya et al. Aloe vera on skin.
CN101879295B (zh) 一种治疗血瘀型银屑病的中药消银汤
CN105125655B (zh) 一种治疗真菌感染引起皮肤痕痒的外用药物及其制备方法
CN100340263C (zh) 一种用于治疗细菌性阴道炎的栓剂及其制备方法
CN115006309B (zh) 一种改善微循环美白组合物、改善微循环美白精华液及其制备方法和应用
CN106924443A (zh) 一种治疗老年性皮肤瘙痒症的外用油及其制备方法
CN101337006B (zh) 一种治疗痤疮粉刺的复合擦剂
CN1088811A (zh) 统癣液
CN107496810A (zh) 一种治疗白癜风的中药组合物
CN101229336B (zh) 一种治疗顽癣的外用药

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180814